Skip to content

Clinical Performance of Investigational InRhythm PT/INR System in a Professional Use Setting

Clinical Performance of the Investigational InRhythm PT/INR System in a Professional Use Setting

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02586818
Enrollment
0
Registered
2015-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Dyscrasia

Brief summary

This study is designed to evaluate and verify the clinical accuracy of the InRhythm PT/INR system; a point-of-care, whole blood PT/INR measurement with a reference plasma based PT/INR using a laboratory reference instrument and reagent (Sysmex/lnnovin) calibrated to the WHO rTF09 reference standard.

Interventions

None listed

Sponsors

University of Rochester
CollaboratorOTHER
Accriva Diagnostics
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

- All * The subjects must be \> 18 years of age. * The subjects must be willing and competent to sign an informed consent. * The subjects must be able to attend the clinic for one visit to donate one FS blood sample and one venous blood draw of approximately 10 cc.

Exclusion criteria

- All * The subject is unable to donate fingerstick and venous blood samples. * The subject has a history of clinically significant bleeding associated with incising the finger and/or the venipuncture. * The subject is enrolled in any other study that involves an investigational drug and/or device. Additional Inclusion Criteria - Therapeutic Group * The subject must require oral VKA anticoagulant therapy. * The patient must have been anticoagulated for at least three months prior to enrollment. Additional

Design outcomes

Primary

MeasureTime frame
Comparison of INR measurements5 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026